• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素 β 与皮肌炎中 1 型干扰素诱导基因表达相关。

Interferon β is associated with type 1 interferon-inducible gene expression in dermatomyositis.

机构信息

Department of Neurology, Division of Neuromuscular Disease, Brigham and Women's Hospital and Children's Hospital Informatics Program, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

出版信息

Ann Rheum Dis. 2011 May;70(5):831-6. doi: 10.1136/ard.2010.139949. Epub 2010 Dec 21.

DOI:10.1136/ard.2010.139949
PMID:21177291
Abstract

OBJECTIVES

To determine whether type 1 interferon (IFN) proteins in blood are associated with downstream type 1 IFN-inducible gene expression in blood from patients with myositis.

METHODS

IFNα, IFNβ and IFNω concentrations were measured by ELISA in 129 blood samples (from 93 patients with dermatomyositis (DM), inclusion body myositis, polymyositis and other muscle diseases and from 36 healthy volunteers). Their concentrations were correlated with their ability to stimulate type 1 IFN-inducible gene transcription in a functional assay for 123 of these samples and the type 1 IFN-inducible blood gene expression from 70 of the same samples.

RESULTS

Blood IFNβ concentration was uniquely associated with DM (p=0.0004), detectable in 64% of samples from patients with untreated or minimally treated DM and 35% of all DM samples compared with 6% of other inflammatory myopathy and 6% of healthy volunteer samples. Blood IFNβ, but not IFNα or IFNω, correlated with high blood type 1 IFN-inducible gene expression (p=0.01). Healthy volunteer samples with a high ELISA signal for IFNα and IFNω lacked functional bioassay activity and such a signal was confirmed as artefactual.

CONCLUSION

Elevated blood IFNβ protein concentration is associated with DM. Systemic and local production of IFNβ might contribute to, but may not fully explain, the marked overproduction of type 1 IFN-inducible transcripts and proteins seen in DM muscle and blood.

摘要

目的

确定血液中的 1 型干扰素 (IFN) 蛋白是否与肌炎患者血液中 1 型 IFN 诱导基因的下游表达相关。

方法

通过 ELISA 法检测 129 份血样(93 份来自皮肌炎 (DM)、包涵体肌炎、多发性肌炎和其他肌肉疾病患者,36 份来自健康志愿者)中的 IFNα、IFNβ 和 IFNω 浓度。将其浓度与 123 份样本的 1 型 IFN 诱导基因转录的功能测定以及 70 份相同样本的 1 型 IFN 诱导血基因表达的能力进行相关分析。

结果

血 IFNβ 浓度与 DM 具有独特的相关性(p=0.0004),在未经治疗或治疗不足的 DM 患者的 64%的样本中可检测到,在所有 DM 样本中占 35%,而在其他炎症性肌病和 6%的健康志愿者样本中占 6%。血 IFNβ 与高血 1 型 IFN 诱导基因表达相关(p=0.01),但 IFNα 或 IFNω 则不然。健康志愿者样本中 IFNα 和 IFNω 的 ELISA 信号高,但缺乏功能生物测定活性,且该信号被确认为人为假象。

结论

血 IFNβ 蛋白浓度升高与 DM 相关。IFNβ 的全身和局部产生可能有助于但不能完全解释 DM 肌肉和血液中 1 型 IFN 诱导转录物和蛋白质的大量过度产生。

相似文献

1
Interferon β is associated with type 1 interferon-inducible gene expression in dermatomyositis.干扰素 β 与皮肌炎中 1 型干扰素诱导基因表达相关。
Ann Rheum Dis. 2011 May;70(5):831-6. doi: 10.1136/ard.2010.139949. Epub 2010 Dec 21.
2
Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.血液中I型干扰素诱导基因表达存在,且反映皮肌炎和多肌炎的疾病活动情况。
Arthritis Rheum. 2007 Nov;56(11):3784-92. doi: 10.1002/art.22928.
3
Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.皮肌炎中皮肤疾病活动与 1 型干扰素基因特征和干扰素-β的相关性。
Br J Dermatol. 2017 May;176(5):1224-1230. doi: 10.1111/bjd.15006. Epub 2017 Mar 14.
4
Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis.I 型干扰素系统的异常激活可能有助于抗黑色素瘤分化相关基因 5 皮肌炎的发病机制。
Br J Dermatol. 2019 May;180(5):1090-1098. doi: 10.1111/bjd.16917. Epub 2018 Sep 26.
5
Type I interferon pathway in adult and juvenile dermatomyositis.成人和青少年皮肌炎中的 I 型干扰素通路。
Arthritis Res Ther. 2011;13(6):249. doi: 10.1186/ar3531. Epub 2011 Dec 22.
6
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients.一项评估靶向 IFN-α 的单克隆抗体西法利姆单抗的 1b 期临床试验显示,该药可中和皮肌炎和多发性肌炎患者血液中的 I 型 IFN 特征。
Ann Rheum Dis. 2014 Jan;73(1):256-62. doi: 10.1136/annrheumdis-2012-202794. Epub 2013 Feb 23.
7
Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.Ⅰ型和Ⅱ型干扰素在幼年皮肌炎中的肌肉表达增加,并与临床和组织学特征相关。
Arthritis Rheumatol. 2019 Jun;71(6):1011-1021. doi: 10.1002/art.40800. Epub 2019 Apr 30.
8
[Expression of interferon and its correlation with clinical features in idiopathic inflammatory myopathies].[干扰素在特发性炎性肌病中的表达及其与临床特征的相关性]
Zhonghua Yi Xue Za Zhi. 2011 May 10;91(17):1157-60.
9
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.皮肌炎中RIG-I/DDX58介导的固有免疫改变。
J Pathol. 2014 Jul;233(3):258-68. doi: 10.1002/path.4346. Epub 2014 Apr 29.
10
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.系统性红斑狼疮、皮肌炎、类风湿关节炎和硬皮病患者存在共同的 I 型干扰素途径激活。
Ann Rheum Dis. 2011 Nov;70(11):2029-36. doi: 10.1136/ard.2011.150326. Epub 2011 Jul 28.

引用本文的文献

1
Dermatomyositis: focus on cutaneous features, etiopathogenetic mechanisms and their implications for treatment.皮肌炎:关注皮肤特征、发病机制及其对治疗的意义。
Semin Immunopathol. 2025 Aug 6;47(1):32. doi: 10.1007/s00281-025-01054-9.
2
IFN-γ +874 T/A Is Associated with High Levels of Sera CPK in Patients with Inflammatory Myopathies.干扰素-γ +874 T/A与炎性肌病患者血清肌酸磷酸激酶水平升高有关。
Curr Issues Mol Biol. 2025 Jun 27;47(7):492. doi: 10.3390/cimb47070492.
3
Dazukibart for dermatomyositis: expanding the therapeutic arsenal.
用于皮肌炎的大冢奇方:扩充治疗手段
Ann Transl Med. 2025 Jun 27;13(3):24. doi: 10.21037/atm-25-44. Epub 2025 Jun 24.
4
Pharmacokinetics, Safety, and Tolerability of Single-Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double-Blind, Phase 1 Studies.单剂量达祖基巴特在中国和日本健康成年人中的药代动力学、安全性和耐受性:两项随机、双盲、1期研究的结果
Clin Pharmacol Drug Dev. 2025 Aug;14(8):572-582. doi: 10.1002/cpdd.1522. Epub 2025 May 22.
5
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy.针对青少年皮肌炎中的干扰素反应:唾液酸结合免疫球蛋白样凝集素-1作为JAK抑制剂疗效的体外生物标志物
Rheumatology (Oxford). 2025 May 15. doi: 10.1093/rheumatology/keaf227.
6
Spatial Transcriptomics Identifies Immune-Stromal Niches Associated with Cancer in Adult Dermatomyositis.空间转录组学鉴定成人皮肌炎中与癌症相关的免疫基质微环境。
bioRxiv. 2025 Mar 19:2025.03.19.644147. doi: 10.1101/2025.03.19.644147.
7
MDA5 protein mediating persistent ER stress/unfolded protein response contributes to endothelial-mesenchymal-transition of lung microvascular endothelial cell in dermatomyositis.介导持续性内质网应激/未折叠蛋白反应的MDA5蛋白促成皮肌炎中肺微血管内皮细胞的内皮-间充质转化。
Cell Commun Signal. 2025 Mar 23;23(1):149. doi: 10.1186/s12964-025-02159-2.
8
Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis.超敏干扰素定量分析揭示了炎性肌病中不同的细胞因子分泌谱,并且可作为皮肌炎活动的生物标志物。
Front Immunol. 2025 Feb 12;16:1529582. doi: 10.3389/fimmu.2025.1529582. eCollection 2025.
9
Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING-Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy.在一名患有婴儿期起病的与STING相关的血管病且对JAK抑制剂和达祖基巴特治疗无效的患者中,使用阿尼鲁单抗持续抑制干扰素特征。
Arthritis Rheumatol. 2025 Feb 25;77(8):1087-91. doi: 10.1002/art.43145.
10
Serum level of IFN-λ is elevated in idiopathic inflammatory myopathies.特发性炎症性肌病患者血清中干扰素-λ水平升高。
Clin Rheumatol. 2025 Jan;44(1):327-340. doi: 10.1007/s10067-024-07227-5. Epub 2024 Nov 23.